Stay updated on Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.

Latest updates to the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, signaling a minor update to the platform/template used for the study detail page. The change does not modify the study content or displayed data.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page now shows Revision: v3.6.2, representing a minor update to the page's revision history.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page now includes new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and adds Last verified and Last known status was labels; it also shows a revision tag indicating a version update (v3.6.0) rather than changes to study content.SummaryDifference2%

- Check36 days agoChange DetectedThe page shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a software/template version update for the page rendering.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, representing a minor metadata update to the study record. It does not indicate changes to the study data or displayed content beyond the revision label.SummaryDifference0.1%

- Check79 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, reflecting an interface/system release rather than a change to the study record.SummaryDifference0.1%

Stay in the know with updates to Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.